CV CapsoVision, Inc
P/E
--
Forward P/E
--
Price/Sales
26.78
Beta
--
Div Yield
--
Market Cap
--
Company Analysis
Latest News
CapsoVision Receives FDA Clearance for AI Highlights Endoscopy Reading Tool
CapsoVision, Inc. announced it received clearance from the U.S. Food and Drug Administration (FDA) for AI Highlights™, its artificial intelligence-assisted...
CapsoVision Announces $18 Million Registered Direct Offering with Existing Stockholders
CapsoVision, Inc. entered into a securities purchase agreement on September 17, 2026, for a registered direct offering to raise approximately $18 million in...
CapsoVision misses second quarter 2026 estimates as margins contract to 51%
CapsoVision reported second quarter 2026 revenue of $3.64 million, reflecting 10% year-over-year growth but missing analyst estimates. While unit volume for...
CapsoVision, Inc. Q2 2026 Earnings Preview: What Analysts Expect on August 13, 2026
CapsoVision is expected to report Q2 2026 revenue of $3.81 million and a loss per share of $0.13, as the stock currently trades at $6.68, well below the...